NZ337180A - Process for preparing eprosartan at a reduced pressure of 11 inches of Hg using a piperidine catalyst - Google Patents
Process for preparing eprosartan at a reduced pressure of 11 inches of Hg using a piperidine catalystInfo
- Publication number
- NZ337180A NZ337180A NZ337180A NZ33718098A NZ337180A NZ 337180 A NZ337180 A NZ 337180A NZ 337180 A NZ337180 A NZ 337180A NZ 33718098 A NZ33718098 A NZ 33718098A NZ 337180 A NZ337180 A NZ 337180A
- Authority
- NZ
- New Zealand
- Prior art keywords
- inches
- reduced pressure
- eprosartan
- catalyst
- piperidine catalyst
- Prior art date
Links
- 239000002080 C09CA02 - Eprosartan Substances 0.000 title abstract 2
- 239000003054 catalyst Substances 0.000 title abstract 2
- OROAFUQRIXKEMV-LDADJPATSA-N eprosartan Chemical compound C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 OROAFUQRIXKEMV-LDADJPATSA-N 0.000 title abstract 2
- 229960004563 eprosartan Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- QHDUBNMGSDGCKZ-UHFFFAOYSA-N piperidin-1-ium;propanoate Chemical compound CCC(O)=O.C1CCNCC1 QHDUBNMGSDGCKZ-UHFFFAOYSA-N 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3819597P | 1997-02-14 | 1997-02-14 | |
| PCT/US1998/002412 WO1998035963A1 (en) | 1997-02-14 | 1998-02-13 | Process for preparing eprosartan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ337180A true NZ337180A (en) | 2000-11-24 |
Family
ID=21898583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ337180A NZ337180A (en) | 1997-02-14 | 1998-02-13 | Process for preparing eprosartan at a reduced pressure of 11 inches of Hg using a piperidine catalyst |
Country Status (41)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2097408A4 (en) * | 2006-12-27 | 2010-08-25 | Hetero Drugs Ltd | IMPROVED PROCESS FOR THE PREPARATION OF EPROSARTAN |
| EP2295431A3 (en) * | 2007-07-25 | 2011-08-03 | Hetero Drugs Limited | Substantially pure eprosartan free base |
| WO2009013760A2 (en) * | 2007-07-25 | 2009-01-29 | Hetero Drugs Limited | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
| WO2009084028A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
| CN101215284B (zh) * | 2007-12-31 | 2010-10-13 | 浙江华海药业股份有限公司 | 一种改进的依普罗沙坦的制备方法 |
| EP2257540A2 (en) * | 2008-03-31 | 2010-12-08 | Hetero Research Foundation | Improved process for eprosartan intermediate |
| WO2010023688A2 (en) * | 2008-08-25 | 2010-03-04 | Matrix Laboratories Limited | An improved process for the preparation of eprosartan |
| WO2011004384A2 (en) | 2009-06-05 | 2011-01-13 | Glochem Industries Limited | Process for the preparation of eprosartan |
| WO2011051975A1 (en) | 2009-10-30 | 2011-05-05 | Matrix Laboratories Ltd | An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185351A (en) | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
| JP3214856B2 (ja) * | 1990-12-14 | 2001-10-02 | スミスクライン・ビーチャム・コーポレイション | イミダゾリル−アルケン酸 |
| US5395847A (en) * | 1993-12-02 | 1995-03-07 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| MX9605794A (es) * | 1994-05-20 | 1997-12-31 | Smithkline Beecham Corp | Intermediario para preparar un compuesto farmaceuticamente activo. |
-
1998
- 1998-02-10 AR ARP980100585A patent/AR011125A1/es active IP Right Grant
- 1998-02-11 EG EG15598A patent/EG23935A/xx active
- 1998-02-12 IN IN360DE1998 patent/IN187999B/en unknown
- 1998-02-12 PE PE1998000101A patent/PE59299A1/es not_active Application Discontinuation
- 1998-02-12 MA MA24961A patent/MA24470A1/fr unknown
- 1998-02-12 MY MYPI98000577A patent/MY118704A/en unknown
- 1998-02-13 US US09/355,185 patent/US6172237B1/en not_active Expired - Lifetime
- 1998-02-13 SK SK1087-99A patent/SK285036B6/sk not_active IP Right Cessation
- 1998-02-13 PL PL335075A patent/PL192838B1/pl unknown
- 1998-02-13 ZA ZA981207A patent/ZA981207B/xx unknown
- 1998-02-13 AT AT98906229T patent/ATE280765T1/de active
- 1998-02-13 JP JP52813798A patent/JP4537499B2/ja not_active Expired - Fee Related
- 1998-02-13 HU HU0001994A patent/HU228781B1/hu not_active IP Right Cessation
- 1998-02-13 UA UA99084635A patent/UA54487C2/uk unknown
- 1998-02-13 RO RO99-00885A patent/RO119719B1/ro unknown
- 1998-02-13 AP APAP/P/1999/001620A patent/AP1128A/en active
- 1998-02-13 TR TR1999/01936T patent/TR199901936T2/xx unknown
- 1998-02-13 EP EP98906229A patent/EP0970073B1/en not_active Expired - Lifetime
- 1998-02-13 WO PCT/US1998/002412 patent/WO1998035963A1/en not_active Ceased
- 1998-02-13 DE DE69827240T patent/DE69827240T2/de not_active Expired - Lifetime
- 1998-02-13 NZ NZ337180A patent/NZ337180A/xx unknown
- 1998-02-13 EA EA199900740A patent/EA001659B1/ru not_active IP Right Cessation
- 1998-02-13 AU AU61508/98A patent/AU730383B2/en not_active Ceased
- 1998-02-13 SI SI9830722T patent/SI0970073T1/xx unknown
- 1998-02-13 BR BR9808664-2A patent/BR9808664A/pt not_active IP Right Cessation
- 1998-02-13 IL IL13130998A patent/IL131309A/en not_active IP Right Cessation
- 1998-02-13 CZ CZ0285299A patent/CZ296349B6/cs not_active IP Right Cessation
- 1998-02-13 PT PT98906229T patent/PT970073E/pt unknown
- 1998-02-13 CO CO98007700A patent/CO4950550A1/es unknown
- 1998-02-13 ES ES98906229T patent/ES2231963T3/es not_active Expired - Lifetime
- 1998-02-13 KR KR1019997007273A patent/KR100573638B1/ko not_active Expired - Fee Related
- 1998-02-13 ID IDW990839A patent/ID23181A/id unknown
- 1998-02-13 CN CN98802484A patent/CN1085208C/zh not_active Expired - Fee Related
- 1998-02-13 CA CA002281708A patent/CA2281708C/en not_active Expired - Fee Related
- 1998-02-13 DK DK98906229T patent/DK0970073T3/da active
- 1998-04-15 TW TW087101969A patent/TW399050B/zh not_active IP Right Cessation
- 1998-05-24 SA SA98190082A patent/SA98190082B1/ar unknown
-
1999
- 1999-08-10 BG BG103650A patent/BG63804B1/bg unknown
- 1999-08-13 OA OA9900179A patent/OA11146A/en unknown
- 1999-08-13 NO NO19993913A patent/NO317194B1/no not_active IP Right Cessation
-
2002
- 2002-01-28 IN IN58DE2002 patent/IN192743B/en unknown
-
2006
- 2006-04-07 CY CY0600011A patent/CY2555B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA962366B (en) | Recovery of acetic acid from dilute aqueous streams formed during a carbonylation process. | |
| AU5672798A (en) | Process for the production of acetic acid | |
| ZA9986B (en) | Anhydrous carbonylation process for the production of acetic acid. | |
| AU8558591A (en) | Process and catalyst for the production of ethylene and acetic acid | |
| MX9705726A (es) | Amidas del acido alcoximinoacetico. | |
| ZA968622B (en) | Process for the production of acetic acid by the carbonylation of dimethyl ether. | |
| CA2099822A1 (en) | Tri-higher alkyl tin azide and its use | |
| AU2001266986A1 (en) | Process for the synthesis of diaryl esters of dicarboxylic acids | |
| AU7556591A (en) | Microbial production of a novel compound 7,10-dihydroxy-8-octadecenoic acid from oleic acid | |
| CA2256620A1 (en) | A process for preparing certain aza cyclohexapeptides | |
| AU2670295A (en) | Process for the preparation of trihydrated cefixime | |
| MX9703766A (es) | Procedimiento para la preparacion de 5-hidroximetiltiazol. | |
| WO2002083634A3 (en) | Process for the preparation of cefpodoxime acid | |
| WO2001035900A3 (en) | Synthesis of 3-ethoxy-4-ethoxycarbonyl phenyl acetic acid, a key acid synthon of repaglinide | |
| NZ513551A (en) | Novel process for preparing alendronic acid | |
| NO965280D0 (no) | Fremgangsmåte for fremstilling av en spesielt ren monokloreddiksyre | |
| CO4950550A1 (es) | Procedimiento | |
| IL108991A0 (en) | Process | |
| AU1502492A (en) | Process for the enzymatic hydrolysis of a carboxylic acid derivative | |
| CA2195975A1 (en) | An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides | |
| CA2189297A1 (en) | Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives | |
| EP1179599A3 (en) | Method for producing lysine derivative | |
| WO1997008129A1 (de) | Verfahren zur herstellung von n-carboxymethylen-4-chlor-anthranilsäure, sowie deren dialkylestern | |
| GR3030683T3 (en) | NEW PROCESS FOR PREPARING (-)-TRANS-N-p-FLUOROBENZOYLMETHYL-4-(p-FLUOROPHENYL)-3- 3,4-(METHYLENEDIOXY)PHENOXY]METHYL]-PIPERIDINE | |
| CA2339826A1 (en) | Process for the production of n-protected azetidine-2-carboxylic acids (azeohs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |